Jupiter Neurosciences, Inc. financial data

Symbol
JUNS on Nasdaq
Industry
Pharmaceutical Preparations
Location
1001 North Us Hwy 1, Suite 504, Jupiter, FL
State of incorporation
DE
Fiscal year end
December 31
Former names
Jupiter Orphan Therapeutics, Inc. (to 12/5/2017)
Latest financial report
10-K - Q4 2024 - Mar 28, 2025

Key Ratios

Label TTM Value / Value Unit Change %
Return On Equity 75.3 % +16.1%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 33.1M shares
Common Stock, Shares, Outstanding 33.1M shares +24.8%
Common Stock, Value, Issued 3.31K USD +24.8%

Income Statement

Label TTM Value / Value Unit Change %
Net Income (Loss) Attributable to Parent -2.44M USD +49%

Balance Sheet

Label TTM Value / Value Unit Change %
Assets, Current 4.65M USD +16081%
Operating Lease, Right-of-Use Asset 69.6K USD -40%
Other Assets, Noncurrent 3.78K USD 0%
Assets 6.2M USD +4074%
Liabilities, Current 2.01M USD -65.2%
Operating Lease, Liability, Noncurrent 21.2K USD -70.2%
Liabilities 2.03M USD -65.9%
Retained Earnings (Accumulated Deficit) -26M USD -10.3%
Stockholders' Equity Attributable to Parent 4.17M USD
Liabilities and Equity 6.2M USD +4074%

Popular Metrics

Label TTM Value / Value Unit Change %
Common Stock, Shares Authorized 125M shares 0%
Common Stock, Shares, Issued 33.1M shares +24.8%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Deferred Tax Assets, Valuation Allowance 6.06M USD +9.29%
Deferred Tax Assets, Gross 6.06M USD +9.29%
Operating Lease, Liability 71.3K USD -40.3%
Lessee, Operating Lease, Liability, to be Paid 71.8K USD -40.6%
Operating Lease, Liability, Current 50.1K USD +3.88%
Lessee, Operating Lease, Liability, to be Paid, Year Two 50.5K USD 0%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 437 USD -64.4%
Lessee, Operating Lease, Liability, to be Paid, Year Three 21.3K USD 0%
Deferred Tax Assets, Operating Loss Carryforwards 10M USD
Preferred Stock, Shares Authorized 5M shares 0%
Additional Paid in Capital 30.2M USD +69.8%
Preferred Stock, Par or Stated Value Per Share 0 USD/shares 0%